Navigate Up
Launch the Developer Dashboard
The Office of HIV/AIDS Network Coordination (HANC) works with the HIV/AIDS clinical trials networks of the U.S. National Institutes of Health (NIH) with the intent of creating a more integrated, collaborative and flexible research structure. The networks are an affiliated group of national and international medical research institutions and investigators that conduct clinical HIV/AIDS research to develop safe and effective drugs, prevention strategies, and vaccines.
 
Read more about our mission​ ​​​​​​
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

photo

​Get Involved in HIV/AIDS Clinical Trials

Learn more about participating in a clinical research study or engaging your community in clinical trials research.

Calandar Image

HANC Calendar

​Check for scientific conferences, network meetings, community events, training dates, etc. 

Training Resources

​View a variety of training resources including the online HIV Research Counseling and Testing (HRCT) curriculum, HSP and GCP training.

Lab Resources

​Find info for labs such as procedures and SOPs.

 

ACTG/IMPAACT Lab Manual Link

 

​Legacy Project

Learn how HANC is working to increase participation of underrepresented populations in HIV clinical trials.




HANC is supported through a cooperative
agreement with the National Institute of Allergy
and Infectious Disease (NIAID)

Find us, follow us, friend us:

   Link to FHCRC

Announ​cem​ents ​

COVID-19 Resources

HANC will maintain and frequently update a new page: Resources and information on the COVID-19 pandemic with a focus on the intersection with the HIV pandemic. Find the page under the Resources tab or link directly here​.


Network Announcements on COVID-19
HIV/AIDS Clinical Trials Network announcements in response to COVID-19 are also available here​

Laboratory Guidance related to COVID-19 is available here​


 ​

ART Adherence and the Promise of Long-Acting Injectable HIV Treatment

June 3, 2020 at 10am PT/11am ET

Important inequities in antiretroviral therapy (ART) adherence and viral suppression persist and large proportions of individuals in care lack durable suppression over extended time intervals. The Office of HIV/AIDS Network Coordination (HANC) invites you to join Dr. Michael Stirratt for this informative presentation where he will briefly review the current ART adherence research landscape, and then discuss the potential opportunities and challenges that long-acting injectable ART may offer for improving HIV treatment adherence and outcomes. Register here​

HIV Language Guide

In collaboration with the Legacy Project and many other reviewers, the National Institute of Allergy and Infectious Diseases has developed a language guide to encourage the use of affirming and non-stigmatizing language among NIAID staff. Access the document here​.  


Guidance for Transgender Inclusive Research

The Division of AIDS Cross-Network Transgender Working Group has released a document to focus attention on inclusive practices for study protocol development and design, data collection, and data reporting. Click here to access the document.


Community Resource - Long-Acting Antiretroviral Injectables Info Sheet

A Long-Acting Antiretroviral Injectables (LAARVI) Information Sheet was developed on behalf of Legacy to provide general information about LAARVI. The info sheet can be found on the Community Resources page or directly linked here.

Digg Delicious Facebook Newsvine Reddit StumbleUpon Twitter Email Link

share:

SiteMap

sitemap:

© HIV/AIDS Network Coordination